The expanding reach of GLP-1 research and the role of the diet-induced obesity (DIO) model
Glucagon-like peptide-1 (GLP-1) agonists, such as semaglutide and liraglutide, are major anti-obesity and anti-diabetes therapeutics that have produced clinically meaningful metabolic benefits. While...
Strain Selection for IMQ-Induced Psoriasis Studies
The imiquimod (IMQ)-induced psoriasis model is widely used in preclinical dermatology research due to its ability to rapidly generate localized skin inflammation that resembles key features of human...
Novel Polymer-Based Orthopedic Implant Shows Complete Integration, Healing, And Safety In A Multi-Year Sheep Study
Key Takeaways: Traditional inert and bioabsorbable orthopedic implants demonstrate several drawbacks, including inflammation or infection, often requiring follow-up surgeries. A biointegrative,...
Decoding the Revised OECD 487 Guideline: What Inotiv Clients Need to Know
Navigating the Latest Changes in In Vitro Micronucleus Testing and What It Means for YouKey Takeaways1. Spotlight on Test Guideline 487 Updates:Uncover key adjustments introduced in the updated...
Advantages of Non-Remitting Chronic IBD Models
The Advantages of Non-Remitting Chronic IBD Rodent ModelsAs the frequency of inflammatory bowel disease (IBD) increases globally, preclinical researchers continue to study new treatments that can...
Promoting Animal Welfare with Implanted Telemetry
As part of the advanced surgical services offered by Inotiv, telemetry represents an important part of a thoughtful, experimental design. Learn how telemetered data can promote animal welfare,...
-1.jpg)
A Consultative Approach to Deliver Excellent Client Experiences
Helping clients realize the full potential of their critical R&D projects starts with a trusted partnership. From research models to specialized services, our team at Envigo–an Inotiv company,...
